Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Revenue

Shukra Pharmaceuticals had revenue of 65.01M INR in the quarter ending June 30, 2025, with 66.88% growth. This brings the company's revenue in the last twelve months to 393.99M, down -34.87% year-over-year. In the fiscal year ending March 31, 2025, Shukra Pharmaceuticals had annual revenue of 367.94M, down -51.88%.

• Revenue (ttm): 393.99M
• Revenue Growth: -34.87%
• P/S Ratio: 30.29
• Revenue / Employee: 2.16M
• Employees: 182
• Market Cap: 11.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	367.94M	-396.72M	-51.88%
Mar 31, 2024	764.66M	169.73M	28.53%
Mar 31, 2023	594.93M	390.07M	190.41%
Mar 31, 2022	204.86M	92.90M	82.97%
Mar 31, 2021	111.96M	-6.50M	-5.49%